Human vascular endothelial cells express epithelial growth factor in response to infection by Bartonella bacilliformis.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
04 2020
Historique:
received: 15 01 2020
accepted: 18 03 2020
revised: 29 04 2020
pubmed: 18 4 2020
medline: 1 7 2020
entrez: 18 4 2020
Statut: epublish

Résumé

Bartonella are Gram-negative bacterial pathogens that trigger pathological angiogenesis during infection of humans. Bartonella bacilliformis (Bb) is a neglected tropical agent endemic to South America, where it causes Carrión's disease. Little is known about Bb's virulence determinants or how the pathogen elicits hyperproliferation of the vasculature, culminating in Peruvian warts (verruga peruana) of the skin. In this study, we determined that active infection of human umbilical vein endothelial cells (HUVECs) by live Bb induced host cell secretion of epidermal growth factor (EGF) using ELISA. Killed bacteria or lysates of various Bb strains did not cause EGF production, suggesting that an active infection was necessary for the response. Bb also caused hyperproliferation of infected HUVECs, and the mitogenic response could be inhibited by the EGF-receptor (EGFR) inhibitor, AG1478. Bb strains engineered to overexpress recombinant GroEL, evoked greater EGF production and hyperproliferation of HUVECs compared to control strains. Conditioned (spent) media from cultured HUVECs that had been previously infected by Bb were found to be mitogenic for naïve HUVECs, and the response could be inhibited by EGFR blocking with AG1478. Bb cells and cell lysates stimulated HUVEC migration and capillary-like tube formation in transmigration and Matrigel assays, respectively. To our knowledge, this is the first demonstration of EGF production by Bb-infected endothelial cells; an association that could contribute to hyperproliferation of the vascular bed during bartonellosis.

Identifiants

pubmed: 32302357
doi: 10.1371/journal.pntd.0008236
pii: PNTD-D-20-00076
pmc: PMC7190185
doi:

Substances chimiques

Epidermal Growth Factor 62229-50-9

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008236

Subventions

Organisme : NIAID NIH HHS
ID : R15 AI119798
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Protoc. 2010 Apr;5(4):628-35
pubmed: 20224563
Infect Immun. 2003 Dec;71(12):6933-42
pubmed: 14638782
Cell Microbiol. 2001 Sep;3(9):623-32
pubmed: 11553014
Adv Med Sci. 2014 Sep;59(2):221-6
pubmed: 25051417
J Physiol. 1999 Jul 15;518 ( Pt 2):315-24
pubmed: 10381581
J Exp Med. 2004 Nov 15;200(10):1267-78
pubmed: 15534369
PLoS One. 2014 Jul 17;9(7):e102739
pubmed: 25033458
Front Cell Infect Microbiol. 2018 Jan 15;7:541
pubmed: 29379775
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):856-61
pubmed: 15642951
Anal Biochem. 1986 Jan;152(1):136-40
pubmed: 3954035
Cell Microbiol. 2001 Mar;3(3):169-80
pubmed: 11260140
PLoS Pathog. 2006 Nov;2(11):e115
pubmed: 17121462
Mol Microbiol. 2004 Apr;52(1):81-92
pubmed: 15049812
Infect Immun. 2006 Sep;74(9):5185-90
pubmed: 16926411
J Biol Chem. 1997 Sep 12;272(37):23247-54
pubmed: 9287333
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
pubmed: 16829981
J Lab Clin Med. 1994 Oct;124(4):521-8
pubmed: 7523553
Infect Immun. 2005 Sep;73(9):5735-42
pubmed: 16113290
Reprod Sci. 2017 Sep;24(9):1245-1252
pubmed: 27920343
Circulation. 2005 Mar 1;111(8):1054-62
pubmed: 15723970
PLoS Negl Trop Dis. 2017 Jun 19;11(6):e0005684
pubmed: 28628613
Ann N Y Acad Sci. 2005 Dec;1063:286-98
pubmed: 16481529
PLoS One. 2011;6(5):e20204
pubmed: 21637717
Infect Immun. 2002 Aug;70(8):4564-70
pubmed: 12117969
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2919
pubmed: 25032975
Am J Pathol. 1990 May;136(5):1125-35
pubmed: 1693472
Appl Environ Microbiol. 1999 Aug;65(8):3441-8
pubmed: 10427032

Auteurs

Linda D Hicks (LD)

Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America.

Michael F Minnick (MF)

Program in Cellular, Molecular & Microbial Biology, Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH